高级检索
许秋菊, 侯莉莉, 毋小魁, 谢松强, 胡国强, 黄文龙. 环丙氟喹诺酮C3/C7双腙的合成及抗肿瘤活性[J]. 中国药科大学学报, 2013, 44(1): 35-38. DOI: 10.11665/j.issn.1000-5048.20130105
引用本文: 许秋菊, 侯莉莉, 毋小魁, 谢松强, 胡国强, 黄文龙. 环丙氟喹诺酮C3/C7双腙的合成及抗肿瘤活性[J]. 中国药科大学学报, 2013, 44(1): 35-38. DOI: 10.11665/j.issn.1000-5048.20130105
XU Qiuju, HOU Lili, WU Xiaokui, XIE Songqiang, HU Guoqiang, HUANG Wenlong. Synthesis and antitumor activity of ciprofloquinolone bis-(C3/C7 hydrazone)s[J]. Journal of China Pharmaceutical University, 2013, 44(1): 35-38. DOI: 10.11665/j.issn.1000-5048.20130105
Citation: XU Qiuju, HOU Lili, WU Xiaokui, XIE Songqiang, HU Guoqiang, HUANG Wenlong. Synthesis and antitumor activity of ciprofloquinolone bis-(C3/C7 hydrazone)s[J]. Journal of China Pharmaceutical University, 2013, 44(1): 35-38. DOI: 10.11665/j.issn.1000-5048.20130105

环丙氟喹诺酮C3/C7双腙的合成及抗肿瘤活性

Synthesis and antitumor activity of ciprofloquinolone bis-(C3/C7 hydrazone)s

  • 摘要: 用酰腙及腙分别作为抗菌氟喹诺酮类药物环丙沙星C3羧基和C7哌嗪基的等排体,设计合成了10个未见文献报道的双腙1-环丙基-6-氟-3-(取代苯叉肼酰基)-7-(取代苯叉肼基)-喹啉-4(1H)-酮( 3a~3j )新化合物。体外抗肿瘤活性实验发现,双腙化合物对L1210、HL60和CHO 3种肿瘤细胞抑制活性远高于母体环丙沙星。这表明C3羧基和C7哌嗪基不是抗肿瘤活性所必需的药效团,可被其电子等排体取代,进一步扩展了结构修饰的范围。

     

    Abstract: To further explore an efficient route for the development of antitumor fluoroquinolone agents,acylhydrazone and hydrazone as isosteric replacements corresponding to C-3 carboxylic acid group and C-7 piperazine group for ciprofloxacin resulted in ten novel title compounds,thus 1-cycloproyl-6-fluoro-7-(substituted)-N′-benzylidene hydrazine-3-(substituted) benzylidene-hydrazino-carbonyl-quinolin-4(1H)-ones( 3a-3j ),which were synthesized with their structures characterized by corresponding spectral data.The in vitro antitumor activity against L1210,CHO and HL60 cell lines was significantly higher potency than that of parent ciprofloxacin,suggesting that it is unnecessary for an antitumor fluoroquinolone to retain a C-3 carboxyl and a C-7 piperazine ring.

     

/

返回文章
返回